Early Data Signal Response With CBX-12 in Advanced or Metastatic Solid Tumors

Funda Meric-Bernstam, MD, discusses the safety of CBX-12 and exploring dosage of the agent.

Related Keywords

Texas ,United States ,Houston ,Nellieb Connally , ,University Of Texas Md Anderson Cancer Center ,Phasei Program ,Institute For Personalized Cancer Therapy ,Department Of Investigational Cancer Therapeutics ,Funda Meric Bernstam ,Investigational Cancer Therapeutics ,Personalized Cancer Therapy ,Breast Cancer ,Cancer Center ,Cbx 12 ,Patients With Advanced Or Metastatic Solid Tumors ,D ,Nct04902872 ,The University Of Texas Md Anderson Cancer Center ,